Analysis
CVS Health's Comeback Is Just Getting Started -- and Its Valuation Still Looks Shockingly Cheap
A Motley Fool analyst believes CVS Health stock is still cheap relative to its potential, with a recovery underway that could drive shares higher.
June 16, 2026
1 min read
Source: Motley Fool
Share:
A Motley Fool analyst argues that CVS Health (NYSE: CVS) remains shockingly cheap despite early signs of a turnaround. The stock may offer a compelling value opportunity for investors.
Why Is the Stock Cheap?
- Price-to-earnings ratio at historically low levels vs. healthcare peers.
- Strong cash flows not yet reflected in the price.
- Operational recovery from the medical claims crisis not fully priced in.
Signs of Recovery
- Improving profit margins in the health insurance segment.
- Growth in Medicare Advantage membership.
- Cost-cutting initiatives starting to pay off.
Risks to Watch
- Continued medical claims pressure.
- Competition from other insurers.
- Potential regulatory changes.
What This Means for Investors
While optimistic, caution is warranted. The analysis is not a buy recommendation but suggests the stock may be undervalued if the recovery materializes.
Frequently Asked Questions
Because its P/E ratio is historically low versus healthcare peers, despite strong cash flows and early operational recovery.
Found this useful? Share it
Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.